A combination of GlaxoSmithKline’s GSK744 and J&J’s TMC278 monthly injection therapy, designed to evaluate its potential to control HIV, is currently being tested. Results of a study, which was conducted on 40 HIV-negative ...
Tags: Injection Therapy, Medicine
US-based Bioject Medical Technologies has entered into three international distribution agreements for the sale of its Biojector2000 gas-powered device, the Bioject ZetaJet spring-powered device and accessories. The company will ...